The Future of Nano-Robotics in Medical Applications

Abstract

Nanorobotics is one of the most radical advances of recent medicine, which can allow making new diagnosis, treatment, and prevention of diseases more accurate than ever before. As a field involving the design and deployment of nanoscale constructs to sense, actuate, compute and intervene into biological systems, medical nanorobots can fundamentally transform the system of healthcare through enabling highly efficient, patient specific and minimally invasive therapies. The current paper is a forward looking analysis of the future of nanorobotics in the medical field based on technological building blocks, research ongoing, clinical opportunity, and major challenges which were not resolved as of today. This introduction to the abstract is the limitations of traditional medical interventions that comprise systemic drug toxicity, invasive surgical procedures, delayed diagnostics and poor specificity of treatment. Nanorobots, that are of the same size scale as biological molecules like proteins, DNA and viruses, provide a paradigm shift since they are able to interact with cell and molecular processes in real time. Such systems combine technologies in the fields of nanotechnology, materials science, micro-electromechanical systems (MEMS), artificial intelligence, and biomedical engineering to bring to fruition applications like targeted drug delivery, precision surgery on individual cells, automated disease surveillance, and regenerative medicine. A review of the development of medical nanorobotics has been given with the theoretical models of nanorobotics, experimental prototypes such as DNA-based nanorobots, magnetically actuated nanomachines, and bio-hybrid systems actuated by living cells. The suggested design provides a type of a modular nanorobot design that includes sensing, control, propulsion, and therapeutic modules with external imaging and control systems. Nanoparticle navigation, drug release and swarm coordination mathematical models are also addressed. Moreover, the experimental and simulated findings presented in the current literature are also compared and assessed on the basis of performance indicators, including targeting accuracy, biocompatibility, therapeutic efficacy, and safety. Critical analysis is made on ethical and regulatory issues as well as translation issues such as immune response, large-scale production, and clinical validation. The paper finds the conclusion that even though important issues still exist, with further interdisciplinary studies and regulation harmonization, nanorobotics might become the foundation of next-generation precision medicine.